Skip to main content
Erschienen in: International Ophthalmology 1/2024

01.12.2024 | Original Paper

Vision-related quality of life in patients with retinal vein occlusion

verfasst von: Shahrokh Ramin, Fatemeh Rostami, Hamid Ahmadieh, Narsis Daftarian, Ramin Nourinia, Ali Abbasi, Bahareh Kheiri, Hamideh Sabbaghi, Kourosh Sheibani

Erschienen in: International Ophthalmology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aims to assess the vision-related quality of life in patients with retinal vein occlusion (RVO) among those referred to Labbafinejad Medical Center and Imam Hossein Hospital between 2019 and 2021.

Methods

This comparative study included 37 eligible patients diagnosed with various types of RVO, with an average age of 61 ± 9. To ensure data validity, we included 74 age- and sex-matched healthy individuals. Only cases with a definitive diagnosis of RVO, confirmed by two retina specialists (ND and RN), were included. We assessed the vision-related quality of life of our participants using the National Eye Institute Visual Functioning Questionnaire-25 (NEI-VFQ-25). All participants underwent interviews.

Results

In our study, we examined the vision-related quality of life in different subgroups of RVO patients. Overall, RVO patients had a significantly lower total VRQoL score compared to healthy individuals (P < 0.001), except in the subscale analysis of specific factors such as ocular pain, color vision, and driving, where no statistically significant difference was observed. A statistically significant difference was found in the comparison of subgroups, indicating lower VRQoL in central retinal vein occlusion (CRVO) patients (P = 0.010). Furthermore, a significant correlation was observed between lower VRQoL and decreased vision (P = 0.009) as well as longer disease duration (P = 0.011).

Conclusion

Retinal vein occlusion can significantly reduce vision-related quality of life, particularly in more severe cases.
Literatur
1.
Zurück zum Zitat Laouri M, Chen E, Looman M, Gallagher M (2011) The burden of disease of retinal vein occlusion: review of the literature. Eye (Lond) 25(8):981–988CrossRefPubMed Laouri M, Chen E, Looman M, Gallagher M (2011) The burden of disease of retinal vein occlusion: review of the literature. Eye (Lond) 25(8):981–988CrossRefPubMed
2.
Zurück zum Zitat Ip M, Hendrick A (2018) Retinal vein occlusion review. Asia Pac J Ophthalmol (Phila) 7(1):40–45PubMed Ip M, Hendrick A (2018) Retinal vein occlusion review. Asia Pac J Ophthalmol (Phila) 7(1):40–45PubMed
3.
4.
Zurück zum Zitat The Eye Disease Case-control Study Group (1993) Risk factors for branch retinal vein occlusion. Am J Ophthalmol 116(3):286–296CrossRef The Eye Disease Case-control Study Group (1993) Risk factors for branch retinal vein occlusion. Am J Ophthalmol 116(3):286–296CrossRef
5.
Zurück zum Zitat Klein R, Klein BE, Moss SE, Meuer SM (2000) The epidemiology of retinal vein occlusion: the beaver dam eye study. Trans Am Ophthalmol Soc 98:133–141 (discussion 141–3)PubMedPubMedCentral Klein R, Klein BE, Moss SE, Meuer SM (2000) The epidemiology of retinal vein occlusion: the beaver dam eye study. Trans Am Ophthalmol Soc 98:133–141 (discussion 141–3)PubMedPubMedCentral
6.
Zurück zum Zitat Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P (2001) Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 131(1):61–77CrossRefPubMed Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P (2001) Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 131(1):61–77CrossRefPubMed
7.
Zurück zum Zitat Martin SC, Butcher A, Martin N, Farmer J, Dobson PM, Bartlett WA et al (2002) Cardiovascular risk assessment in patients with retinal vein occlusion. Br J Ophthalmol 86(7):774–776CrossRefPubMedPubMedCentral Martin SC, Butcher A, Martin N, Farmer J, Dobson PM, Bartlett WA et al (2002) Cardiovascular risk assessment in patients with retinal vein occlusion. Br J Ophthalmol 86(7):774–776CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Hu CC, Ho JD, Lin HC (2009) Retinal vein occlusion and the risk of acute myocardial infarction (correction of infraction): a 3-year follow-up study. Br J Ophthalmol 93(6):717–720CrossRefPubMed Hu CC, Ho JD, Lin HC (2009) Retinal vein occlusion and the risk of acute myocardial infarction (correction of infraction): a 3-year follow-up study. Br J Ophthalmol 93(6):717–720CrossRefPubMed
9.
Zurück zum Zitat Song P, Xu Y, Zha M, Zhang Y, Rudan I (2019) Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health 9(1):010427CrossRefPubMedPubMedCentral Song P, Xu Y, Zha M, Zhang Y, Rudan I (2019) Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health 9(1):010427CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Wong TY, Larsen EK, Klein R, Mitchell P, Couper DJ, Klein BE et al (2005) Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the atherosclerosis risk in communities & cardiovascular health studies. Ophthalmology 112(4):540–547CrossRefPubMed Wong TY, Larsen EK, Klein R, Mitchell P, Couper DJ, Klein BE et al (2005) Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the atherosclerosis risk in communities & cardiovascular health studies. Ophthalmology 112(4):540–547CrossRefPubMed
11.
Zurück zum Zitat Yasuda M, Kiyohara Y, Arakawa S, Hata Y, Yonemoto K, Doi Y et al (2010) Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci 51(6):3205–3209CrossRefPubMed Yasuda M, Kiyohara Y, Arakawa S, Hata Y, Yonemoto K, Doi Y et al (2010) Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci 51(6):3205–3209CrossRefPubMed
12.
Zurück zum Zitat Rogers SL, McIntosh RL, Lim L, Mitchell P, Cheung N, Kowalski JW et al (2010) Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 117(6):1094-1101.e5CrossRefPubMed Rogers SL, McIntosh RL, Lim L, Mitchell P, Cheung N, Kowalski JW et al (2010) Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 117(6):1094-1101.e5CrossRefPubMed
13.
Zurück zum Zitat Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD et al (2001) Development of the 25-item national eye institute visual function questionnaire. Arch Ophthalmol 119(7):1050–1058CrossRefPubMed Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD et al (2001) Development of the 25-item national eye institute visual function questionnaire. Arch Ophthalmol 119(7):1050–1058CrossRefPubMed
14.
Zurück zum Zitat Asgari S, Hashemi H, Nedjat S, Shahnazi A, Fotouhi A (2011) Persian version of the 25-item national eye institute visual functioning questionnaire (NEI-VFQ25): a validaton study. Iran J Ophthalmol 23(3):5–14 Asgari S, Hashemi H, Nedjat S, Shahnazi A, Fotouhi A (2011) Persian version of the 25-item national eye institute visual functioning questionnaire (NEI-VFQ25): a validaton study. Iran J Ophthalmol 23(3):5–14
15.
Zurück zum Zitat Klein R, Moss SE, Klein BE, Gutierrez P, Mangione CM (2001) The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol 119(5):733–740CrossRefPubMed Klein R, Moss SE, Klein BE, Gutierrez P, Mangione CM (2001) The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol 119(5):733–740CrossRefPubMed
16.
Zurück zum Zitat Revicki DA, Rentz AM, Harnam N, Thomas VS, Lanzetta P (2010) Reliability and validity of the national eye institute visual function questionnaire-25 in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 51(2):712–717CrossRefPubMed Revicki DA, Rentz AM, Harnam N, Thomas VS, Lanzetta P (2010) Reliability and validity of the national eye institute visual function questionnaire-25 in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 51(2):712–717CrossRefPubMed
17.
Zurück zum Zitat Kumar S, Thakur S, Ichhpujani P (2019) The impact of primary open-angle glaucoma: comparison of vision-specific (national eye institute visual function questionnaire-25) and disease-specific (glaucoma quality of life-15 and viswanathan 10) patient-reported outcome (PRO) instruments. Indian J Ophthalmol 67(1):83–88CrossRefPubMedPubMedCentral Kumar S, Thakur S, Ichhpujani P (2019) The impact of primary open-angle glaucoma: comparison of vision-specific (national eye institute visual function questionnaire-25) and disease-specific (glaucoma quality of life-15 and viswanathan 10) patient-reported outcome (PRO) instruments. Indian J Ophthalmol 67(1):83–88CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Scott IU, Smiddy WE, Schiffman J, Feuer WJ, Pappas CJ (1999) Quality of life of low-vision patients and the impact of low-vision services. Am J Ophthalmol 128(1):54–62CrossRefPubMed Scott IU, Smiddy WE, Schiffman J, Feuer WJ, Pappas CJ (1999) Quality of life of low-vision patients and the impact of low-vision services. Am J Ophthalmol 128(1):54–62CrossRefPubMed
19.
Zurück zum Zitat Deramo VA, Cox TA, Syed AB, Lee PP, Fekrat S (2003) Vision-related quality of life in people with central retinal vein occlusion using the 25-item national eye institute visual function questionnaire. Arch Ophthalmol 121(9):1297–1302CrossRefPubMed Deramo VA, Cox TA, Syed AB, Lee PP, Fekrat S (2003) Vision-related quality of life in people with central retinal vein occlusion using the 25-item national eye institute visual function questionnaire. Arch Ophthalmol 121(9):1297–1302CrossRefPubMed
20.
Zurück zum Zitat Awdeh RM, Elsing SH, Deramo VA, Stinnett S, Lee PP, Fekrat S (2010) Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item national eye institute visual function questionnaire. Br J Ophthalmol 94(3):319–323CrossRefPubMed Awdeh RM, Elsing SH, Deramo VA, Stinnett S, Lee PP, Fekrat S (2010) Vision-related quality of life in persons with unilateral branch retinal vein occlusion using the 25-item national eye institute visual function questionnaire. Br J Ophthalmol 94(3):319–323CrossRefPubMed
21.
Zurück zum Zitat Prem Senthil M, Khadka J, Gilhotra JS, Simon S, Fenwick EK, Lamoureux E, Pesudovs K (2019) Understanding quality of life impact in people with retinal vein occlusion: a qualitative inquiry. Clin Exp Optom 102(4):406–411CrossRefPubMed Prem Senthil M, Khadka J, Gilhotra JS, Simon S, Fenwick EK, Lamoureux E, Pesudovs K (2019) Understanding quality of life impact in people with retinal vein occlusion: a qualitative inquiry. Clin Exp Optom 102(4):406–411CrossRefPubMed
22.
Zurück zum Zitat Okamoto F, Tomioka M, Murakami T, Morikawa S, Sugiura Y, Hiraoka T et al (2021) Relationship between stereopsis and vision-related quality of life following intravitreal ranibizumab injections for central retinal vein occlusion. Sci Rep 11(1):20475ADSCrossRefPubMedPubMedCentral Okamoto F, Tomioka M, Murakami T, Morikawa S, Sugiura Y, Hiraoka T et al (2021) Relationship between stereopsis and vision-related quality of life following intravitreal ranibizumab injections for central retinal vein occlusion. Sci Rep 11(1):20475ADSCrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Murakami T, Okamoto F, Sugiura Y, Morikawa S, Okamoto Y, Hiraoka T et al (2022) visual functions affecting vision-related quality of life following intravitreal ranibizumab therapy for central retinal vein occlusion. J Clin Med 11(14):4139CrossRefPubMedPubMedCentral Murakami T, Okamoto F, Sugiura Y, Morikawa S, Okamoto Y, Hiraoka T et al (2022) visual functions affecting vision-related quality of life following intravitreal ranibizumab therapy for central retinal vein occlusion. J Clin Med 11(14):4139CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Bonomi AE, Patrick DL, Bushnell DM, Martin M (2000) Validation of the United States’ version of the World Health Organization Quality of Life (WHOQOL) instrument. J Clin Epidemiol 53(1):1–12CrossRefPubMed Bonomi AE, Patrick DL, Bushnell DM, Martin M (2000) Validation of the United States’ version of the World Health Organization Quality of Life (WHOQOL) instrument. J Clin Epidemiol 53(1):1–12CrossRefPubMed
25.
Zurück zum Zitat Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD (1998) Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investig Arch Ophthalmol 116(11):1496–1504 Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD (1998) Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investig Arch Ophthalmol 116(11):1496–1504
26.
27.
Zurück zum Zitat Behboudi H, Nikkhah H, Alizadeh Y, Katibeh M, Pakbin M, Ahmadieh H et al (2020) A Population-based study on the prevalence and associated factors of age-related macular degeneration in northern iran the gilan eye study. Ophthalmic Epidemiol 27(3):209–218CrossRefPubMed Behboudi H, Nikkhah H, Alizadeh Y, Katibeh M, Pakbin M, Ahmadieh H et al (2020) A Population-based study on the prevalence and associated factors of age-related macular degeneration in northern iran the gilan eye study. Ophthalmic Epidemiol 27(3):209–218CrossRefPubMed
29.
Zurück zum Zitat Katibeh M, Moghaddam A, Yaseri M, Neupane D, Kallestrup P, Ahmadieh H (2020) Hypertension and associated factors in the Islamic Republic of Iran: a population-based study. East Mediterr Health J 26(3):304–314CrossRefPubMed Katibeh M, Moghaddam A, Yaseri M, Neupane D, Kallestrup P, Ahmadieh H (2020) Hypertension and associated factors in the Islamic Republic of Iran: a population-based study. East Mediterr Health J 26(3):304–314CrossRefPubMed
30.
Zurück zum Zitat Fujiwara T, Yano Y, Hoshide S, Kanegae H, Kario K (2018) Association of cardiovascular outcomes with masked hypertension defined by home blood pressure monitoring in a japanese general practice population. JAMA Cardiol 3(7):583–590CrossRefPubMedPubMedCentral Fujiwara T, Yano Y, Hoshide S, Kanegae H, Kario K (2018) Association of cardiovascular outcomes with masked hypertension defined by home blood pressure monitoring in a japanese general practice population. JAMA Cardiol 3(7):583–590CrossRefPubMedPubMedCentral
Metadaten
Titel
Vision-related quality of life in patients with retinal vein occlusion
verfasst von
Shahrokh Ramin
Fatemeh Rostami
Hamid Ahmadieh
Narsis Daftarian
Ramin Nourinia
Ali Abbasi
Bahareh Kheiri
Hamideh Sabbaghi
Kourosh Sheibani
Publikationsdatum
01.12.2024
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 1/2024
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-024-02916-1

Weitere Artikel der Ausgabe 1/2024

International Ophthalmology 1/2024 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Metastase in der periokulären Region

Metastasen Leitthema

Orbitale und periokuläre metastatische Tumoren galten früher als sehr selten. Aber mit der ständigen Aktualisierung von Medikamenten und Nachweismethoden für die Krebsbehandlung werden neue Chemotherapien und Strahlenbehandlungen eingesetzt. Die …

Staging und Systemtherapie bei okulären und periokulären Metastasen

Metastasen Leitthema

Metastasen bösartiger Erkrankungen sind die häufigsten Tumoren, die im Auge diagnostiziert werden. Sie treten bei ungefähr 5–10 % der Patienten mit soliden Tumoren im Verlauf der Erkrankung auf. Besonders häufig sind diese beim Mammakarzinom und …

Wundheilung nach Trabekulektomie

Trabekulektomie CME-Artikel

Die überschießende Wundheilung in der filtrierenden Glaukomchirurgie ist ein zentraler Faktor für ein operatives Versagen. Nach der Einführung der Trabekulektomie in den 1960er-Jahren wurden viele Faktoren erkannt, die mit einer vermehrten …

„standard operating procedures“ (SOP) – Vorschlag zum therapeutischen Management bei periokulären sowie intraokulären Metastasen

Metastasen Leitthema

Peri- sowie intraokuläre Metastasen sind insgesamt gesehen selten und meist Zeichen einer fortgeschrittenen primären Tumorerkrankung. Die Therapie ist daher zumeist palliativ und selten kurativ. Zudem ist die Therapiefindung sehr individuell. Die …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.